SanBio Company Limited
TSE:4592.T
962 (JPY) • At close September 13, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | SanBio Company Limited |
Symbool | 4592.T |
Munteenheid | JPY |
Prijs | 962 |
Beurswaarde | 66,022,475,584 |
Dividendpercentage | 0% |
52-weken bereik | 380 - 1,489 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Mr. Keita Mori MBA |
Website | https://www.sanbio.jp |
An error occurred while fetching data.
Over SanBio Company Limited
SanBio Company Limited develops, produces, and sells regenerative cell medicines for the central nervous system. The company develops SB623 that has completed a phase 2 clinical trial to treat traumatic brain injury in the United States and Japan. Its research pipeline products also comprise SB623 for ischemic and hemorrhagic strokes,
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (JPY)
Cijfers zijn in miljoenen (JPY)